MAMMATYPER
Dead / Cancelled — Cancelled — Section 8 (as of 10 Mar 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86692541
- Registration number
- 5025192
- Mark type
- Word mark
- Filed
- 14 Jul 2015
- Published for opposition
- 07 Jun 2016
- Registered
- 23 Aug 2016
- Attorney of record
- Allison R. Imber, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Reagents, in-vitro diagnostic preparations and in-vitro diagnostic kits primarily comprised of diagnostic reagents and assays for testing body fluids and tissue samples for the diagnosis of breast cancer, prediction of breast cancer and stratification of patients for relevant breast cancer therapies, all for medical and veterinary purposes
- Class 042 — Scientific and technological services: Analytical laboratory services in the nature of medical and scientific laboratory services; medical and scientific laboratory services; laboratory research in the field of biomarker expression in cancer; laboratory testing and laboratory analysis services in the nature of scientific research in the field of cancer; advisory services relating to laboratory tests in the field of cancer research; laboratory research services relating to pharmaceuticals; clinical science, medical, pharmaceutical, genetic science and biotechnology research and development services; conducting protein-chemical, DNA, RNA or immunohistochemical tests for scientific purposes, in particular for the development of breast cancer therapies and breast cancer therapeutics
- Class 044 — Medical, beauty and agricultural services: Medical and veterinary laboratory testing services relating to the treatment of humans and animals; medical laboratory testing services for the analysis of samples of patients; medical testing services of a medical laboratory relating to the treatment of humans and animals; protein-chemical, DNA, RNA or immunohistochemical testing services for medical purposes, in particular for the diagnosis of breast cancer, prediction of breast cancer and stratification of patients for relevant breast cancer therapies
Owner
- BioNTech Diagnostics GmbH, Mainz, DE
- BioNTech Diagnostics GmbH, Mainz, DE
- BioNTech Diagnostics GmbH, Mainz, DE
Prosecution history
- 10 Mar 2023 — CANCELLED SEC. 8 (6-YR)
- 23 Aug 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Aug 2016 — REGISTERED-PRINCIPAL REGISTER
- 07 Jun 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jun 2016 — PUBLISHED FOR OPPOSITION
- 18 May 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 May 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 25 Apr 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Apr 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Apr 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Apr 2016 — ASSIGNED TO LIE
- 01 Apr 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Oct 2015 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Oct 2015 — NON-FINAL ACTION E-MAILED
- 26 Oct 2015 — NON-FINAL ACTION WRITTEN